









Markets
/
Stocks
/
nasdaq-ste
/

STERIS plc

STE

243.985USD

+1.955+0.81%

Market hours （ET）Quotes delayed by 15 min

24.03BMarket Cap

37.17P/E TTM



STERIS plc

243.985

+1.955+0.81%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of STERIS plc

Currency: USD Updated: 2025-10-21

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

STERIS plc's Score

Industry at a Glance

Industry Ranking

21 / 204

Overall Ranking

70 / 4687

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 9 analysts

Buy

Current Rating

272.418

Target Price

+12.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

STERIS plc Highlights

StrengthsRisks

STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 20.35% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 5.46B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 36.04%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.04%.

Undervalued

The company’s latest PE is 36.85, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 94.84M shares, decreasing 3.20% quarter-over-quarter.

Held by Al Gore

Star Investor Al Gore holds 3.17M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-21

The company's current financial score is 9.51, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.39B, representing a year-over-year increase of 8.72%, while its net profit experienced a year-over-year increase of 22.01%.

Score

Industry at a Glance

Previous score

9.51

Change



Financials

7.62

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.93

Key Metrics

Free cash flow

No Data

STERIS plc's Company Valuation

Currency: USD Updated: 2025-10-21

The company’s current valuation score is 4.92, which is lower than the Healthcare Equipment & Supplies industry's average of 7.16. Its current P/E ratio is 36.85, which is 458.62% below the recent high of 205.87 and 12236.64% above the recent low of -4472.70.

Score

Industry at a Glance

Previous score

4.92

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 21/204

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-21

The company’s current earnings forecast score is 7.78, which is higher than the Healthcare Equipment & Supplies industry's average of 7.72. The average price target for STERIS plc is 280.00, with a high of 295.00 and a low of 231.34.

Score

Industry at a Glance

Previous score

7.78

Change

Support & Resistance

No Data

Analyst Rating

Based on 9 analysts

Buy

Current Rating

272.418

Target Price

+12.47%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

116

Total

Median

Average

Company name

Ratings

Analysts

STERIS plc

STE

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-21

The company’s current price momentum score is 7.32, which is higher than the Healthcare Equipment & Supplies industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 250.58 and the support level at 232.99, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.22

Change

0.1

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.314

Neutral

RSI(14)

50.042

Neutral

STOCH(KDJ)(9,3,3)

70.728

Buy

ATR(14)

4.026

High Vlolatility

CCI(14)

80.706

Neutral

Williams %R

24.980

Buy

TRIX(12,20)

-0.139

Sell

StochRSI(14)

96.602

Overbought

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

240.304

Buy

MA10

239.239

Buy

MA20

241.643

Buy

MA50

245.024

Sell

MA100

239.734

Buy

MA200

231.747

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-21

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.37. The latest institutional shareholding proportion is 96.30%, representing a quarter-over-quarter increase of 2.06%. The largest institutional shareholder is The Vanguard, holding a total of 12.12M shares, representing 12.31% of shares outstanding, with 2.34% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

12.12M

+1.72%

BlackRock Institutional Trust Company, N.A.

5.59M

-2.93%

MFS Investment Management

4.66M

-3.51%

State Street Investment Management (US)

4.19M

+2.40%

Generation Investment Management LLP

Star Investors

3.17M

-5.48%

Morgan Stanley Investment Management Ltd. (UK)

2.57M

-1.36%

Geode Capital Management, L.L.C.

2.48M

+1.93%

Orbis Investment Management Ltd.

2.10M

+36.02%

WCM Investment Management

2.10M

-53.40%

Select Equity Group, L.P.

2.05M

-7.35%

Risk Assessment

Currency: USD Updated: 2025-10-21

The company’s current risk assessment score is 9.61, which is higher than the Healthcare Equipment & Supplies industry's average of 4.64. The company's beta value is 1.02. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.